Please provide your email address to receive an email when new articles are posted on . The dual therapy group experienced a reduction in tear breakup time and greater corneal epithelial thinning.

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Atropine eye drops showed efficacy in slowing myopia ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

The short-term use of atropine eye drops to treat myopia in children did not affect long-term visual outcomes, the prospective observational ATLAS study of participants from two randomized trials ...

Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these ...

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each ...

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...

Treating U.S. children with an investigational low-dose (0.01%) formulation of atropine eye drops didn't delay worsening of nearsightedness, a randomized clinical trial found. Over 24 months, kids ...

Orthokeratology and 0.01% atropine eye drops are said to stop a child's vision from getting worse “My daughter Samantha got glasses in second grade,” says Yiwen Lee, a mother of two and an airline ...